Lower-intensity anticoagulation for mechanical heart valves: A new concept with the ATS bileaflet aortic valve

Journal of Heart Valve Disease

Volumn 12, Issue 4, 2003, Pages 495-502

  Van Nooten, Guido J ^a   Van Belleghem, Yves ^a   Caes, Frank ^a   François, Katrien ^a   Van Overbeke, Hans ^a   Bové, Thiery ^a   Taeymans, Yves ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; TICLOPIDINE;

ADULT; AGE; AGED; AORTA VALVE DISEASE; AORTA VALVE PROSTHESIS; AORTA VALVE REPLACEMENT; ARTICLE; BLEEDING; CAROTID ARTERY SURGERY; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DEATH; DEFIBRILLATION; EQUIPMENT DESIGN; EXPLANT; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE CONTRACTILITY; HEART LEFT VENTRICLE FUNCTION; HUMAN; INTERNATIONAL STANDARD UNIT; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; MYOMECTOMY; PRIORITY JOURNAL; PROSPECTIVE STUDY; REOPERATION; RISK FACTOR; SINUS RHYTHM; STATISTICAL ANALYSIS; SURGICAL TECHNIQUE; SURVIVAL; THROMBOEMBOLISM; TREATMENT OUTCOME;

AGED; ANTICOAGULANTS; AORTIC VALVE; AORTIC VALVE INSUFFICIENCY; BELGIUM; FEMALE; FOLLOW-UP STUDIES; HEART VALVE PROSTHESIS; HUMANS; INTERNATIONAL NORMALIZED RATIO; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; POSTOPERATIVE COMPLICATIONS; PROPORTIONAL HAZARDS MODELS; PROSTHESIS DESIGN; REOPERATION; RISK FACTORS; SURVIVAL ANALYSIS; TIME FACTORS; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT;

EID: 0042062267     PISSN: 09668519     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Emery RW, Van Nooten GJ, Tesar PJ. The initial experience with the ATS Medical Mechanical Cardiac Valve Prosthesis. Ann Thorac Surg 2003;75:444-452
2. Verdonck PJ, Van Nooten GJ, Van Belleghem Y. Pulse duplicator hydrodynamics of four different bileaflet valves in mitral position. Cardiovasc Surg 1997;6:593-604
3. Kelly SG, Verdonck PR, Vierendels JA, Riemslagh K, Dick E, Van Nooten G. A three-dimensional analysis of flow in the pivot regions of an ATS bileaflet valve. Int J Artif Organs 1999;22:754-763
4. Butchart EG, Lewis PA, Grunkemeier GL, Kutatilake N, Breckenridge I. Low risk of thrombosis and serious embolic events despite low-intensity anticoagulation: Experience with 1004 Medtronic Hall valves. Circulation 1988;78(suppl.I):166-177
5. Horstkotte D, Schulte H, Bircks W, Strauer B. Lower intensity anticoagulation therapy results in lower complication rates with the St. Jude Medical prosthesis. J Thorac Cardiovasc Surg 1994;107:1136-1145
6. Edmunds LH, Jr., Clark LE, Cohn LH, Grunkemeier GL, Miller DC, Weisel RD. Guidelines for reporting morbidity and mortality after cardiac valvular operations. Ann Thorac Surg 1996;62:932-935
7. Arom KV, Nicoloff DM, Kersten TE, Northrup WF, Lindsay WG, Emery RW. Ten years of experience with the St. Jude Medical valve prosthesis. Ann Thorac Surg 1989;47:831-837
8. de Luca L, Vitale N, Giannolo B, Cafarella G, Piazza L, Cotrufo M. Mid-term follow-up after heart valve replacement with the CarboMedics bileaflet prostheses. J Thorac Cardiovasc Surg 1993;106:1158-1165
9. Arom KV, Nicoloff DM, Kersten TE, Northrup WF, III, Lindsay WG, Emery RW. Ten years follow-up study of patients who had double valve replacement with the St. Jude Medical valve prosthesis. J Thorac Cardiovasc Surg 1989;98:1008-1016
10. Kuntze C, Ebels T, Eijgelaer A, Homan Van Der Heide JN. Rates of thromboembolism with three different mechanical heart valve prosthesis; randomised study. Lancet 1989;11:514-517
11. Akins C. Mechanical cardiac valvular prosthesis. Ann Thorac Surg 1991;52:161-172
12. Nakano K, Koyanagi H, Hashimoto A, et al. Twelve years experience with the St. Jude Medical valve prosthesis. Ann Thorac Surg 1994;57:697-703
13. Altman R, Rouvier J, Garfunkel E, et al. Comparison of two levels of anticoagulant therapy in patients with substitute heart valves. J Thorac Cardiovasc Surg 1991;101:427-431
14. Altman R, Rouvier J, Gurfinkel E, Scazziota A, Turpie A. Comparison of high dose with low-dose aspirin in patients with mechanical heart valve replacement treated with oral anticoagulant. Circulation 1996;94:2113-2116
15. Moake JL, Turner NA, Stathopoulos NA, Nolasco L, Hellums JD. Shear-induced platelet aggregation can be mediated by von Willebrand factor released from platelets, as well as by exogenous large or unusual large vWF multimers, requires adenosine diphosphate, and is resistant to aspirin. Blood 1988;71:1366-1374
16. Okita Y, Miki S, Kusuhara K, et al. Intractable hemolysis caused by perivalvular leakage following mitral valve replacement with St. Jude Medical prosthesis. Ann Thorac Surg 1988;46:89-92
17. Acar J, Iung B, Boissel JP, et al. AREVA: Multicenter randomized comparison of low-dose versus standard-dose anticoagulation in patients with mechanical prosthetic heart valves. Circulation 1996;94:2107-2116